Pricing Log in Create free account

BRIACELL THERAP (BCTX) vs Quince Therapeutics, Inc. (IRLA)

BRIACELL THERAP and Quince Therapeutics, Inc. are both Biotechnology companies. BRIACELL THERAP and Quince Therapeutics, Inc. are of similar size ($33.8M and $32.8M). Quince Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.5×. Across the 8 metrics below, Quince Therapeutics, Inc. leads on 7 and BRIACELL THERAP on 1.

Valuation

Metric BCTX IRLA Biotechnology median
P/E 1.53 n/m 8.50
P/S n/m n/m 9.71
P/B 1.06 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 65.24% (442.37%) (33.15%)
Free cash flow yield (126.67%) (23.96%) (25.50%)

Profitability

Metric BCTX IRLA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (173.55%) 784.09% (56.36%)
Return on assets (139.20%) (76.68%) (48.04%)
Return on invested capital (3,311.00%) 0.00% 0.00%

Growth

Metric BCTX IRLA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (43.04%) (28.24%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCTX IRLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.07 14.52 4.72
Net debt to EBITDA 0.66 0.00 0.96

Dividend

Metric BCTX IRLA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCTX IRLA Biotechnology median
Market cap 32.76m 33.79m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack